FDA-2024-0081-V081

Minor variation for application FDA-2024-0081. Minor variation: Formulation Change for Lorlatenilib — routine update

Variation Number
FDA-2024-0081-V081
Type
Minor
Application
FDA-2024-0081
Change
CHG-2024-0081
Status
Completed
Fee
€1,106
Submitted
—
Approved
—
Description

Minor variation: Formulation Change for Lorlatenilib — routine update